These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23814523)

  • 21. Barriers to enrollment in non-small cell lung cancer therapeutic clinical trials.
    Baggstrom MQ; Waqar SN; Sezhiyan AK; Gilstrap E; Gao F; Morgensztern D; Govindan R
    J Thorac Oncol; 2011 Jan; 6(1):98-102. PubMed ID: 21150469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
    Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
    Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
    Roth ME; O'Mara AM; Seibel NL; Dickens DS; Langevin AM; Pollock BH; Freyer DR
    J Oncol Pract; 2016 Apr; 12(4):e388-95. PubMed ID: 27026648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study.
    Pole JD; Barber R; Bergeron RÉ; Carret AS; Dix D; Kulkarni K; Martineau E; Randall A; Stammers D; Strahlendorf C; Strother DR; Truong TH; Sung L
    BMC Cancer; 2017 Jun; 17(1):402. PubMed ID: 28583094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
    Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
    Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.
    Goulart BH; Reyes CM; Fedorenko CR; Mummy DG; Satram-Hoang S; Koepl LM; Blough DK; Ramsey SD
    J Oncol Pract; 2013 Jan; 9(1):42-50. PubMed ID: 23633970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.
    Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Sanoff HK; Lund JL
    Oncologist; 2020 Jan; 25(1):46-54. PubMed ID: 31611329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organizational barriers to physician participation in cancer clinical trials.
    Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
    Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population-based study.
    Mobley EM; Charlton ME; Ward MM; Lynch CF
    Cancer; 2019 Jul; 125(13):2283-2290. PubMed ID: 30901085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.
    Kehl KL; Landrum MB; Arora NK; Ganz PA; van Ryn M; Mack JW; Keating NL
    JAMA Oncol; 2015 Apr; 1(1):50-8. PubMed ID: 26182303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists.
    Siminoff LA; Zhang A; Colabianchi N; Sturm CM; Shen Q
    J Clin Oncol; 2000 Mar; 18(6):1203-11. PubMed ID: 10715289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
    Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
    J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist.
    Luo R; Giordano SH; Zhang DD; Freeman J; Goodwin JS
    Cancer; 2007 Mar; 109(5):975-82. PubMed ID: 17265530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.
    Fisch MJ; Lee JW; Weiss M; Wagner LI; Chang VT; Cella D; Manola JB; Minasian LM; McCaskill-Stevens W; Mendoza TR; Cleeland CS
    J Clin Oncol; 2012 Jun; 30(16):1980-8. PubMed ID: 22508819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does enrollment in cancer trials improve survival?
    Chow CJ; Habermann EB; Abraham A; Zhu Y; Vickers SM; Rothenberger DA; Al-Refaie WB
    J Am Coll Surg; 2013 Apr; 216(4):774-80; discussion 780-1. PubMed ID: 23415510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
    Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
    Parsons HM; Harlan LC; Seibel NL; Stevens JL; Keegan TH
    J Clin Oncol; 2011 Oct; 29(30):4045-53. PubMed ID: 21931022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction.
    Keating NL; Weeks JC; Landrum MB; Borbas C; Guadagnoli E
    Med Care; 2001 Jul; 39(7):681-91. PubMed ID: 11458133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.